Director, Oncology Commercial Data Science & AI Products

AstraZeneca•Gaithersburg, MD
•$186,014 - $279,022•Hybrid

About The Position

The Director, Oncology Commercial Data Science & AI Products will lead a multi-indication AI product portfolio end to end and serve as the strategic data science and AI business partner to Oncology Business Unit (OBU) brand and medical leadership. The role owns the responsible design, delivery, adoption, and impact measurement of AI solutions intended to improve commercial performance and patient outcomes across Sales, Marketing, and Medical Affairs. It is a product ownership and program strategy position, not an analytics consulting role, and includes liaison responsibilities between US Oncology and the broader Enterprise AI organization. The role leads the full AI product lifecycle, including problem definition, customer research, requirements, collaboration on AI development and UX, deployment, change management, and post-launch measurement. It combines roadmap and budget planning, product backlog management, GenAI and agentic AI development, cross-functional business partnership, delivery oversight, governance, and value tracking. A platform-centric, reuse-first approach is expected so successful capabilities can scale across indications and functions. The portfolio may include predictive field triggers, patient-identification models, omnichannel next-best-action, KOL intelligence, GenAI field tools, clinical evidence summarization, and natural-language interfaces to analytics. The position works with OBU leadership, brand and medical teams, Enterprise AI engineering, data and analytics groups, compliance partners, vendors, and consulting partners. The role is expected to ensure responsible deployment under enterprise governance, privacy, and compliance requirements, and to measure adoption, output quality, commercial impact, and patient-related outcomes. The position is based on an office-working expectation of an average minimum of three days per week, with flexibility. The listed annual base pay range is $186,014.40–$279,021.60 USD. The role also offers a short-term incentive bonus opportunity and, for salaried roles, eligibility to participate in an equity-based long-term incentive program. Benefits include a qualified retirement program (401(k)), paid vacation and holidays, paid leaves, and health benefits including medical, prescription drug, dental, and vision coverage.

Requirements

  • Bachelor's degree or comparable experience in a quantitative field such as computer science, statistics, engineering, or economics; equivalent relevant experience is accepted.
  • 7–10+ years of professional experience, including 5+ years in pharma commercial functions or pharma-focused strategy consulting.
  • Demonstrated end-to-end AI or data-science product ownership with measurable commercial impact in an oncology or specialty context.
  • Strong analytical fluency and ability to bridge brand strategy, commercial operations, data science, and technology teams in a highly matrixed organization.
  • Hands-on familiarity with LLMs, query crafting, retrieval-augmented generation systems, and agentic frameworks such as LangChain or LlamaIndex, or equivalent.
  • Working proficiency in Python and ML/AI tooling.
  • Experience with cloud platforms such as AWS SageMaker/Athena, Databricks, Azure, or GCP.
  • Deep expertise in oncology commercial data, including secondary claims (IQVIA, Symphony, MMIT), EHR/EMR sources such as Komodo and Veeva PULSE, lab/diagnostic data such as Diaceutics, specialty pharmacy, and enriched ML assets.
  • Exceptional communication, interpersonal, and relationship-management skills, with a consultative approach and ability to operate effectively in highly matrixed organizations.
  • Ability to understand core business goals, set direction, build alignment, and proactively drive work forward in a fast-growing organization.
  • Ability to define product requirements and functional specifications and partner with engineering on governed, scalable AI products.
  • Ability to plan and manage AI product portfolios, backlogs, delivery dependencies, budgets, and stakeholder alignment.
  • Ability to establish use-case success measures and evaluate adoption, output quality, and commercial or patient-related impact.
  • Ability to work within AI governance, compliance, privacy, data-access, and documentation requirements.

Nice To Haves

  • Graduate degree such as an MBA, MS, MD, or PhD in a quantitative, scientific, or business discipline.
  • Demonstrated commercial experience in Oncology.
  • Production GenAI or agentic AI experience in commercial pharma, such as LLM-powered field tools, RAG-based clinical applications, or governed agentic omnichannel workflow automation.
  • Experience with KOL/KEE influence analytics, precision-targeting tools such as EGFR-testing waypoint analysis, or omnichannel next-best-action platforms such as Aktana or Veeva Align.
  • Track record of leading AI-enabled business transformation and change-management programs across large organizations of 1,000+ users.
  • External thought leadership, such as conference presentations or publications in oncology analytics or commercial AI.
  • Applied depth in LLMs and prompt engineering, including GPT-4, Claude, or Gemini; system prompting, few-shot methods, chain-of-thought, and structured output.
  • Applied depth in RAG architectures, including vector stores, chunking strategies, retrieval evaluation, and hallucination mitigation.
  • Experience with LLMOps, including evaluation pipelines, output-quality monitoring, and A/B testing for GenAI applications.
  • Experience with supervised or unsupervised learning, including logistic regression, gradient boosting, clustering, and propensity scoring for patient/HCP targeting.
  • Experience with time-series and sequence models for patient-journey stage prediction and trigger-timing optimization.
  • Experience with causal inference and test-and-control methods for AI impact attribution and commercial ROI measurement.
  • Familiarity with oncology data sources including IQVIA NPA, XPONENT, or DDD; Symphony; MMIT; SaleSEER; Komodo; Veeva PULSE; Diaceutics; and Definitive Health.
  • Familiarity with AWS S3, Athena, SageMaker, or Bedrock; Databricks; Snowflake; and programming languages Python, SQL, R, or SAS.
  • Experience with Tableau, Power BI, or Alteryx.
  • Experience with Agile/Scrum practices, including backlog grooming, sprint planning, user-story writing, acceptance criteria, UAT management, and release approval.
  • Experience with AI governance artifacts and processes, including model/data cards, registry workflows, compliance documentation, and evidence frameworks.
  • Experience collaborating on UX wireframing, user research, persona development, and prototype feedback cycles with field and headquarters teams.
  • Experience with omnichannel integration, including trigger-code design, message alignment, and field activation workflows.

Responsibilities

  • Own the strategy and transformation roadmap for Sales, Marketing, and Medical Affairs AI capabilities across assigned OBU tumor areas, including planning and budget management aligned with the annual cycle.
  • Develop business cases and value narratives for future AI capabilities with OBU franchises, I&A, and Enterprise AI delivery teams, and present them to OBU leadership to support roadmap prioritization.
  • Maintain a prioritized product backlog with user stories, acceptance criteria, and timelines; balance maintenance, innovation pilots, and new-indication onboarding in an agile operating model.
  • Monitor industry, market, and technology developments, including GenAI, agentic AI, oncology data science, and competitor strategies, to keep the roadmap forward-looking.
  • Champion reusable, scalable AI product architecture that can be piloted in one indication and deployed across indications and business units.
  • Define, design, and deliver GenAI applications for commercial and medical teams, including field briefing tools, clinical evidence summarization, agentic omnichannel workflows, and natural-language interfaces to analytics.
  • Write product requirements and functional specifications for LLM-powered, RAG-based, and agentic applications, partnering with Enterprise AI engineering to deliver governed, scalable production solutions.
  • Evaluate GenAI and agentic AI architecture choices against field workflow requirements and apply a pilot-and-scale methodology with defined success criteria, quality measures, and adoption metrics.
  • Serve as the DS&AI business partner and product owner for assigned tumor-area brand teams, Medical Affairs, and Market Access; participate in strategy reviews, launches, and leadership meetings.
  • Lead cross-functional discovery workshops, define AI use cases with problem descriptions, success metrics, data requirements, and risk tiers, and translate findings into engineering user stories.
  • Partner with MSL and medical leadership on scientific use cases, including treatment-pathway analytics, KOL/KEE influence mapping, diagnostic and biomarker testing strategies, and health equity analytics.
  • Own and govern demand-sensing and care-gap workstreams supporting FSIP, forecasting, and field strategy; present roadmaps and field impact at leadership meetings, sales meetings, and steering committees.
  • Set direction for AI capabilities in Sales, Marketing, and Medical Affairs, prioritizing scalable solutions that meet business needs and are embedded in daily field workflows.
  • Identify organizational and process changes needed for AI capabilities and lead change efforts, including communicating the AI transformation narrative to sales and marketing teams.
  • Partner with Business Excellence and Franchise teams to plan and deliver training, field enablement workshops, and persona-aligned onboarding for major capability releases.
  • Drive AI literacy among brand, medical, and field teams through capability reviews, lunch-and-learns, executive presentations, and self-service fluency with AZ AI platforms.
  • Translate business needs into technical requirements; establish RACI and align priorities, dependencies, and timelines with AI division partners and delivery teams.
  • Deliver launch-critical AI results on time, including pre-launch analytics, ML-enriched targeting lists, and predictive triggers using EHR, claims, and lab signals under the AIDLC framework.
  • Monitor portfolio progress and interdependencies, resolve challenges and blockers, and escalate issues to senior leadership with clear framing and proposed solutions.
  • Manage external vendors and consulting partners against deliverables and timelines; support budget management and PMO invoicing.
  • Identify and pilot emerging AI/ML techniques, including LLM field tools, agentic frameworks, biomarker-signal models, multimodal data fusion, and real-world evidence analytics.
  • Lead or co-lead data-source evaluations and communicate data granularity caveats and preprocessing requirements to technical and business audiences.
  • Design and implement a reusable predictive ML trigger ecosystem for earlier patient identification across indications.
  • Develop precision-medicine and earlier-patient-identification strategies that detect high-risk patients upstream of clinical decision points and help reduce diagnostic and treatment delays.
  • Operate within enterprise AI governance requirements, including registry-before-scale, model and data cards, human-in-the-loop oversight, ongoing monitoring, and IT approvals.
  • Manage compliance requirements, data access controls, HIPAA privacy guardrails, and vendor management; ensure responsible deployment and appropriate documentation.
  • Partner with OBEX, FSIP, Legal, Privacy, and I&A to ensure AI-ready data assets are compliant, auditable, and operationalized with standardized QA and refresh cadences.
  • Maintain auditable AIDLC processes and govern UAT, compliance approval, and release gates with scenario-based demonstrations and documented acceptance criteria.
  • Define launch success criteria and KPIs; monitor adoption, output quality, and downstream business impact such as sales lift, patient-identification speed, and care-gap closure.
  • Lead causal-impact assessments to quantify commercial lift attributable to AI applications and triggers, using findings to inform collaboration and investment decisions.
  • Communicate product results and business impact to OBU and enterprise leadership to support investment decisions and roadmap prioritization.

Benefits

  • Short-term incentive bonus opportunity.
  • Eligibility to participate in an equity-based long-term incentive program for salaried roles.
  • Qualified retirement program (401(k)).
  • Paid vacation and holidays.
  • Paid leaves.
  • Medical coverage.
  • Prescription drug coverage.
  • Dental coverage.
  • Vision coverage.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service